Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Merck, which is evaluating the safety and efficacy of enlicitide for the treatment of adults with hyperlipidemia on lipid-lowering therapies, including at least a statin, said the Phase 3 studies met ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced ... Eli Lilly and Company price-consensus-chart | Eli Lilly and Company Quote To ...

Statins, the more commonly used drugs, were also linked to some side effects. For example, some people taking statins might ...

You may need medication, too. But with lifestyle changes such as the TLC Program, you may be able to take lower doses. The goal of cholesterol treatment is to help you prevent a heart attack or ...

NewAmsterdam Pharma said Tuesday its cholesterol drug lowered the risk of major cardiovascular ... Cup With Handle Chart Pattern Over the course of a year, patients who received NewAmsterdam's ...

Ezetimibe is a cholesterol-lowering drug that is often prescribed with statins to reduce LDL even more. The research was presented Wednesday during a late-breaking science session at the ...

But recent research points to an unexpected ally in this fight: the common cholesterol-lowering drugs known as statins. A hidden enemy in cancer’s spread The biggest threat from cancer usually ...

(Reuters) -Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies.